Endologix LLC
(Other OTC/NBB : ELGX)

( )
ELGX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Medical Specialties
TMOThermo Fisher Scientific, Inc. 1.34%465.101.0%$731.52m
ABTAbbott Laboratories -0.02%118.290.8%$614.91m
MDTMedtronic Plc -0.10%125.140.6%$528.59m
DHRDanaher Corp. 0.93%256.000.7%$514.88m
ISRGIntuitive Surgical, Inc. -0.13%832.332.3%$508.48m
BDXBecton, Dickinson & Co. 0.21%243.001.0%$369.30m
BSXBoston Scientific Corp. -0.02%41.541.0%$364.50m
ALGNAlign Technology, Inc. 0.00%569.046.3%$329.80m
DXCMDexCom, Inc. 0.00%333.257.8%$288.03m
SYKStryker Corp. 0.13%253.291.3%$274.34m
EWEdwards Lifesciences Corp. 0.06%89.540.4%$251.67m
BAXBaxter International, Inc. -0.05%83.821.8%$206.38m
AAgilent Technologies, Inc. 0.11%131.301.6%$196.63m
IDXXIDEXX Laboratories, Inc. 0.00%530.073.8%$189.57m
ZBHZimmer Biomet Holdings, Inc. -0.08%167.131.7%$174.37m

Company Profile

Endologix develops and manufactures minimally invasive treatments for aortic disorders. Endologix's flagship product is the Powerlink(R) System, which is an endovascular stent graft for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S.